UNMC part of international hepatitis C registry to improve treatment

The University of Nebraska Medical Center is involved in an international registry that's evaluating new treatments for hepatitis C, a disease that threatens many baby boomers. Many of the estimated 3 million people in the U.S. who have the virus - an overwhelming majority are baby boomers - don't know they are infected. Hepatitis C is responsible for 12,000 deaths annually in the U.S, according to the Centers for Disease Control and Prevention. UNMC, a regional referral center for hepatitis C, is part of the Hepatitis C Therapeutic Registry and Research Network, or HCV-TARGET.